Rimidi Diabetes is a healthcare technology company that finds solutions to diabetes, one of health care’s most pressing problems.
Focused on effectively and safely managing blood glucose, Rimidi’s prescription-only component, Diabetes+Me™ Rx, is a breakthrough software technology targeting the most critical and personal element of diabetes–blood glucose management. It empowers patients and physicians to identify gaps in diabetes management, as well as identifying the necessary steps to close those gaps in order to meet patient glucose targets and create a more efficient cycle of care. The individual can share this data with their healthcare provider, wellness coach or family member to tailor their diabetes management strategy to their unique challenges.
Lucienne Marie Ide, M.D., Ph.D.
Lucie brings her diverse experiences in medicine, science, venture capital and technology to bear in leading Rimidi’s strategy and vision. Motivated by the belief that we can do so much better for patients, Lucie left clinical medicine to join the ranks of healthcare entrepreneurs who are trying to revolutionize an industry.